Vorolanib and everolimus: Lenvatinib and everolimus part deux, or something new?

Por Chehrazi-Raffle, Alexander, Pal, Sumanta Kumar
Publicado no EBioMedicine (2020)

Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations

Por Gong, Jun, Chehrazi-Raffle, Alexander, Reddi, Srikanth, Salgia, Ravi
Publicado no J Immunother Cancer (2018)

Wnt/β-Catenin Signaling and Immunotherapy Resistance: Lessons for the Treatment of Urothelial Carcinoma

Por Chehrazi-Raffle, Alexander, Dorff, Tanya B., Pal, Sumanta K., Lyou, Yung
Publicado no Cancers (Basel) (2021)

The gut microbiome and response to immune checkpoint inhibitors: preclinical and clinical strategies

Por Gong, Jun, Chehrazi-Raffle, Alexander, Placencio-Hickok, Veronica, Guan, Michelle, Hendifar, Andrew, Salgia, Ravi
Publicado no Clin Transl Med (2019)

Renal Cell Carcinoma With Urinary Bladder Metastasis: A Case Report With Metachronous Genomic Analyses

Por Chehrazi-Raffle, Alexander, Malhotra, Jasnoor, Salgia, Sabrina, Favorito, Crystal, Hsu, JoAnn, Wu, Huiqing, Pal, Sumanta K.
Publicado no JCO Precis Oncol (2021)

Circulating cytokines associated with clinical response to systemic therapy in metastatic renal cell carcinoma

Por Chehrazi-Raffle, Alexander, Meza, Luis, Alcantara, Marice, Dizman, Nazli, Bergerot, Paulo, Salgia, Nicholas, Hsu, JoAnn, Ruel, Nora, Salgia, Sabrina, Malhotra, Jasnoor, Karczewska, Ewa, Kortylewski, Marcin, Pal, Sumanta
Publicado no J Immunother Cancer (2021)

Spontaneous coronary artery dissection: Case series from two institutions with literature review

Por Uribe, Carlos Esteban, Ramirez-Barrera, Juan David, Rubio, Carlos, Gallegos, Cesia, Ocampo, Luz Adriana, Saldarriaga, Clara, Eusse, Carlos, Tenorio, Carlos, Lopez, Nilson, Moreno, Andres, Jaramillo, Natalia Gonzalez, Chehrazi-Raffle, Alexander Morteza, Singh, Vikas, Martinez-Clark, Pedro
Publicado no Anatol J Cardiol (2015)